VLDL metabolism

Latest news

Tag

Dapagliflozin and Lipoprotein Metabolism in Type 2 Diabetes: Preserving LDL Catabolism and Normalizing VLDL Processing

This study demonstrates that dapagliflozin does not impair LDL catabolism but favorably shifts VLDL1 and VLDL2 catabolism toward normal physiology in type 2 diabetes, potentially contributing to reduced atherosclerosis risk.

Jul 31, 2026

Gastroenterology

Can a smartphone app replace in-person hypnotherapy for IBS? Trial finds non-inferiority not demonstrated, but response rates suggest a viable alternative

A multicentre RCT found that smartphone-based self-guided hypnotherapy did not meet non-inferiority to in-person therapy for IBS abdominal pain, though both hypnotherapy arms outperformed psychoeducation.

Jul 29, 2026Sign in to read

Respiratory

Oral Appliances Found Non-Inferior to CPAP for Sleep Apnea in Sequential Effectiveness Study

A prospective non-randomized study found mandibular advancement devices non-inferior to CPAP in a combined efficacy-adherence measure (MDA), with higher nightly adherence and patient preference, but study design limits interpretation.

Jul 27, 2026Sign in to read